Metropolitan Life Insurance Company (MetLife)’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-4,708
| Closed | -$12.6K | – | 2389 |
|
2022
Q1 | $12.6K | Sell |
4,708
-6,734
| -59% | -$18K | ﹤0.01% | 2229 |
|
2021
Q4 | $49.5K | Buy |
11,442
+4,796
| +72% | +$20.8K | ﹤0.01% | 2701 |
|
2021
Q3 | $33.8K | Sell |
6,646
-12,278
| -65% | -$62.5K | ﹤0.01% | 2796 |
|
2021
Q2 | $120K | Buy |
18,924
+2,569
| +16% | +$16.3K | ﹤0.01% | 2503 |
|
2021
Q1 | $126K | Buy |
16,355
+11,905
| +268% | +$92K | ﹤0.01% | 2318 |
|
2020
Q4 | $29.1K | Sell |
4,450
-9,990
| -69% | -$65.4K | ﹤0.01% | 2504 |
|
2020
Q3 | $96K | Sell |
14,440
-194
| -1% | -$1.29K | ﹤0.01% | 2242 |
|
2020
Q2 | $122K | Buy |
14,634
+5,858
| +67% | +$48.8K | ﹤0.01% | 2132 |
|
2020
Q1 | $67.3K | Sell |
8,776
-3,195
| -27% | -$24.5K | ﹤0.01% | 2268 |
|
2019
Q4 | $99.5K | Sell |
11,971
-6,711
| -36% | -$55.8K | ﹤0.01% | 2337 |
|
2019
Q3 | $138K | Buy |
18,682
+5,098
| +38% | +$37.6K | ﹤0.01% | 2124 |
|
2019
Q2 | $152K | Buy |
13,584
+1,575
| +13% | +$17.7K | ﹤0.01% | 2071 |
|
2019
Q1 | $129K | Sell |
12,009
-1,470
| -11% | -$15.8K | ﹤0.01% | 2174 |
|
2018
Q4 | $204K | Buy |
13,479
+562
| +4% | +$8.49K | ﹤0.01% | 1813 |
|
2018
Q3 | $239K | Hold |
12,917
| – | – | ﹤0.01% | 1886 |
|
2018
Q2 | $295K | Buy |
12,917
+3,432
| +36% | +$78.5K | ﹤0.01% | 1678 |
|
2018
Q1 | $270K | Buy |
9,485
+187
| +2% | +$5.32K | ﹤0.01% | 1695 |
|
2017
Q4 | $196K | Sell |
9,298
-7,878
| -46% | -$166K | ﹤0.01% | 1920 |
|
2017
Q3 | $312K | Hold |
17,176
| – | – | ﹤0.01% | 2007 |
|
2017
Q2 | $266K | Hold |
17,176
| – | – | ﹤0.01% | 2162 |
|
2017
Q1 | $297K | Hold |
17,176
| – | – | ﹤0.01% | 2005 |
|
2016
Q4 | $189K | Hold |
17,176
| – | – | ﹤0.01% | 2379 |
|
2016
Q3 | $269K | Hold |
17,176
| – | – | ﹤0.01% | 2141 |
|
2016
Q2 | $175K | Buy |
+17,176
| New | +$175K | ﹤0.01% | 2410 |
|